Runs PACE centers giving frail seniors all-inclusive medical, social and transportation care so they can stay home.
Runs PACE centers giving frail seniors all-inclusive medical, social and transportation care so they can stay home.
Receives a fixed monthly payment per enrolled senior from Medicare and the state Medicaid programme, and must cover all that person's care out of it, so profit depends on keeping medical costs below the payment. Growth depends on enrolling more members and on regulators approving expansions; it listed in 2021.
Moat: narrow (regulatory licence, installed base). PACE is a capped, state-licensed model; incumbents hold scarce enrollment slots and centers.
Headquarters: Denver, Colorado, US · Employees: 2,500
Size InnovAge (INNV) is a United States Information Technology company (Packaged Software) with a market value of $1.22B, the 2109th largest of 3,085 United States companies the cockpit tracks. Shares closed at $8.91 on 18 Nov 2026.
Performance Over six months the shares gained 18.6%, against -20.1% for the median peer and -2.2% for the United States market (cap-weighted) — 6th highest of 20 in its peer set.
Growth Revenue grew 15.1% over the last twelve months (peer median +8.1%); the operating margin is 7.7% (peer median 4.1%).
Valuation It trades at 19.7× forward earnings against a peer median of 23.2× (6th cheapest of 14).
Price implies For today's price to make sense, revenue must grow about -6% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is -16 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 18.8 points above its cost of capital (6.5% WACC).
Short interest Short interest is 0.7% of the free float (30 Oct 2026).
Next results Next results expected around 9 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|---|
| Revenue | $1.02B | $990M | $854M | $764M | $688M |
| Revenue growth | — | +16% | +12% | +11% | — |
| Gross profit | $218M | $207M | $134M | $113M | $85.9M |
| EBITDA | $99.9M | $87.4M | $26.6M | $1.73M | -$18.5M |
| Net income | $9.00M | -$2.54M | -$30.3M | -$21.3M | -$40.7M |
| Free cash flow | $76.3M | $50.4M | $26.6M | -$44.8M | -$3.12M |
| Capital expenditure | $13.2M | $14.3M | $6.26M | $7.91M | $23.4M |
| Total debt | $83.9M | $87.0M | $101M | $113M | $109M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| InnovAge INNV | $1.22B | +19% | +15% | 8% | 19.7× | -6.5% |
| Humana HUM | $46.3B | +27% | +22% | 2% | 22.1× | 5.5% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | INNV | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -2.6% | -10.2% | 4th highest of 21 |
| 6-month return | +18.6% | -20.1% | 6th highest of 20 |
| Distance from 52-week high | -29.5% | -46.0% | 6th highest of 21 |
| Revenue growth (TTM) | +15.1% | +8.1% | 8th highest of 21 |
| Operating margin | 7.7% | 4.1% | 8th highest of 21 |
| Forward P/E | 19.7× | 23.2× | 6th cheapest of 14 |
| Growth the price implies (Req g, 7 yrs) | -6.5% | 20.1% | 2nd least demanding of 14 |
| Growth delivered (Del g) | +9.2% | +18.2% | 6th lowest of 14 |
| Hurdle (Req g minus delivered) | -15.7 pp | +8.1 pp | 4th least demanding of 14 |
| ROIC minus cost of capital | +18.8 pp | -6.6 pp | highest of 20 |
| EV / EBITDA | 11.7× | 12.8× | 4th cheapest of 9 |
| Net debt / EBITDA | -0.8× | -0.3× | 5th least indebted of 9 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| InnovAge INNV | United States | $1.22B | +19% | +15% | 8% | 19.7× | -6.5% | +9.2% |
| Cyient CYIENT.NS | India | $1.22B | +20% | +10% | 9% | 19.8× | 20.1% | +12.0% |
| Wondershare Technology 300624.SZ | China | $1.21B | -34% | -8% | -12% | n/a | n/a | n/a |
| Datang Telecom Technology 600198.SS | China | $1.21B | -34% | -11% | -30% | n/a | n/a | n/a |
| Modern Times Group MTG MTG-A.ST | Sweden | $1.22B | +12% | +21% | 11% | 7.4× | -8.1% | +23.7% |
| Hangzhou DPTech Technology 300768.SZ | China | $1.23B | -25% | -3% | 5% | 38.6× | 32.3% | +6.5% |
| Richinfo Technology 300634.SZ | China | $1.19B | -24% | -11% | 10% | 28.7× | 19.2% | +19.9% |
| Opera Limited Sponsored ADR OPRA | United States | $1.24B | -20% | +23% | 16% | 11.8× | 3.8% | +30.1% |
| CHAPTERS CHG.DE | Germany | $1.24B | +36% | +63% | -21% | n/a | 43.8% | +178.6% |
| freee K.K 4478.T | Japan | $1.19B | +50% | +26% | 4% | 55.3× | 41.6% | +32.8% |
| PagerDuty PD | United States | $1.24B | +121% | +2% | 7% | 11.2× | 13.4% | +18.2% |
| Longshine Technology 300682.SZ | China | $1.24B | -45% | +7% | -9% | 23.2× | 46.5% | +6.0% |
| Digiwin 300378.SZ | China | $1.26B | -17% | +10% | 9% | 26.3× | n/a | n/a |
| Baige Online Digital Technology 2672.HK | Hong Kong | $1.18B | n/a | +34% | -3% | n/a | 53.3% | +41.4% |
| Bingo Software 688227.SS | China | $1.17B | -29% | -7% | -11% | n/a | n/a | n/a |
| Phancy 6682.HK | Hong Kong | $1.26B | -45% | +42% | -5% | 74.9× | n/a | n/a |
| Corsair Gaming CRSR | United States | $1.27B | +69% | +2% | 3% | 15.1× | 22.2% | -2.9% |
| Shenzhen Kingdom Sci-tech 600446.SS | China | $1.27B | -28% | -22% | -6% | 159.9× | n/a | n/a |
| Fengzhushou 301382.SZ | China | $1.16B | -42% | +28% | 8% | n/a | n/a | n/a |
| Genimous Technology 000676.SZ | China | $1.15B | -11% | +3% | 6% | n/a | 11.8% | -17.5% |
| Zensar Technologies ZENSARTECH.NS | India | $1.28B | +7% | +9% | 14% | 15.7× | 11.7% | +8.5% |